You are the profession. Have your say.™

tags

Blog

• Associations
• Company News
• Congress & Conferences
• CPD & Events
• News
• Products & Launches
• Universities

Species

• Equine
• Exotic
• Farm animal
• Small animal

archives

2010

• August
• July
• June
• May
• April
• March
• February
• January

2009

• December
• November
• October
• September
• August
• July
• June
• May
• April
• March
• February
• January

View all blog posts

blog posts

• New Merck begins operations following completion of merger with Schering-Plough

  

  Merck has outlined its global plans following the completion of its merger with Schering-Plough on 3 November.…

  By: David Watson
  Published: 05 Nov 2009
  0 Comments

• CEVA launches Florkem for treatment of respiratory disease in cattle and pigs

  

  CEVA Animal Health has extended its range of injectable anti-infectives with the launch of Florkem. The product is a fluorfenicol-based antimicrobial for use in the treatment of respiratory tract infections in cattle and pigs.…

  By: David Watson
  Published: 04 Nov 2009
  0 Comments

• BVA says ‘no' to VMD's proposed new medicines category

  

  The British Veterinary Association and its divisions have combined forces to oppose a new veterinary medicines category proposed by the UK Veterinary Medicines Directorate.…

  By: David Watson
  Published: 02 Nov 2009
  0 Comments

• VetCell becomes UK's first authorised equine stem cell centre

  

  VetCell Bioscience has become the first UK-based stem cell centre to be authorised under the Veterinary Medicines Regulations.…

  By: David Watson
  Published: 01 Nov 2009
  0 Comments

• Progress on human Group B streptococcus vaccine may have implications for bovine mastitis control

  

  US scientists have completed a Phase II clinical study that indicates a vaccine to prevent Group B streptococcus (GBS) infection in humans is possible.…

  By: John Bonner
  Published: 30 Oct 2009
  0 Comments

• CEVA trials show triple synchronisation can increase pregnancy rates and cut costs

  

  According to CEVA, trials* comparing three commercially available synchronisation protocols have confirmed that pregnancy rates may be improved by up to 35% by using triple synchronisation with PRID (3PSynch).…

  By: David Watson
  Published: 29 Oct 2009
  0 Comments